- Filed
- Jun 1, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2019 · Dec 31, 2019 | 18.33M sh |
| Short Term Debt | FY 2019 · Dec 31, 2018 | $3.64M |
| Stockholders Equity | FY 2019 · Dec 31, 2018 | $52.61M |
| Current Liabilities | FY 2019 · Dec 31, 2018 | $17.89M |
| Total Liabilities | FY 2019 · Dec 31, 2018 | $17.89M |
| Current Assets | FY 2019 · Dec 31, 2018 | $58.94M |
| Total Assets | FY 2019 · Dec 31, 2018 | $71.21M |
| Shares Diluted | FY 2019 · Dec 31, 2017 | 18.33M sh |
| Capex | FY 2019 · Dec 31, 2017 | $2.08M |
| Operating Cash Flow | FY 2019 · Dec 31, 2017 | $3M |
| Eps Diluted | FY 2019 · Dec 31, 2017 | $0.48 |
| Eps Basic | FY 2019 · Dec 31, 2017 | $0.48 |
| Sga Expense | FY 2019 · Dec 31, 2017 | $14.77M |
| Rd Expense | FY 2019 · Dec 31, 2017 | $3.55M |
| Net Income restated | FY 2019 · Dec 31, 2017 | $9.12M |
| Operating Income | FY 2019 · Dec 31, 2017 | $8.64M |
| Gross Profit | FY 2019 · Dec 31, 2017 | $23.41M |
| Cost Of Revenue | FY 2019 · Dec 31, 2017 | $65.56M |
| Revenue | FY 2019 · Dec 31, 2017 | $88.97M |
| Cash And Equivalents restated | FY 2019 · Dec 31, 2016 | $16.45M |